April 11, 2018 / 9:49 AM / 11 days ago

BRIEF-Hubei Biocause Pharmaceutical's Preliminary 2017 Net Profit Down, Sees Q1 Net Profit Rising

April 11 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd :

* SAYS PRELIM 2017 NET PROFIT DOWN 21.9 PERCENT AT 1.4 BILLION YUAN ($222.79 million)

* SAYS IT SEES Q1 NET PROFIT TO RISE 172.7-218.2 PCT Y/Y VS 110 MLN YUAN YEAR AGO

* SAYS INSURANCE UNIT'S Q1 PREMIUM INCOME TOTALLED 27.15 BILLION YUAN Source text in Chinese: bit.ly/2v63iKP; bit.ly/2qpjEJ7; bit.ly/2IIAFFE Further company coverage: ($1 = 6.2840 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below